Should you buy Rocket Lab USA stock now?
No, the technical signal for Rocket Lab USA is currently SELL. Rocket Lab USA trades at $77.72 as of 8/6/2026. The overall technical signal is: Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -5.869 with rising momentum (signal: -7.926); RSI is at 48.4 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $111.31 points to 43.2% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Rocket Lab USA stock?
The average analyst price target for Rocket Lab USA is $111.31. The current price is $77.72, which gives an upside of 43.2%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $100.18 and $122.44.
Is Rocket Lab USA a dividend stock?
No, Rocket Lab USA does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Rocket Lab USA stock?
Rocket Lab USA is rated as a stock with extreme risk. the annual standard deviation is 96.1%, which classifies the stock as extreme risk.
Is Rocket Lab USA overvalued?
No, Rocket Lab USA is considered undervalued based on the analyst price target (43.2% upside). Rocket Lab USA has the following valuation ratios: a P/S ratio of 68.5, a P/B ratio of 17.9. The analyst price target suggests that the stock is undervalued by 43.2%.
Is Rocket Lab USA overbought?
No, Rocket Lab USA is not overbought. RSI is at 48.4 (neutral zone). The technical indicators show: RSI is at 48.4 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 10.4% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Rocket Lab USA earnings report?
Rocket Lab USA reports its next earnings on August 10, 2026. The stock currently trades at $77.72.
Is Rocket Lab USA shorted?
Yes, Rocket Lab USA is shorted with 8.0% of the free float sold short. This is a high level of short selling, which suggests some investors are betting on falling prices. Positive surprises can lead to a moderate short squeeze. Data is updated daily based on official filings with the SEC.
Are insiders buying Rocket Lab USA stock?
No, insiders are not buying Rocket Lab USA shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 15 sales. On a net basis, 107,486,444 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 113,180,375 $ sold. Active sellers include Beck Peter, Kampani Arjun, Slusky Alexander R and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Rocket Lab USA a good stock?
Based on our total score, Rocket Lab USA is rated as a disastrous stock with a total score of 10 out of 100. The stock scores very low on value, quality and momentum – it is among the worst in our database. The score is made up of Value: 4/100, Quality: 12/100, Momentum: 13/100. In addition: analysts see 43.2% upside to the price target; technical signal: Sell. Whether Rocket Lab USA is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Rocket Lab USA stock?
The outlook for Rocket Lab USA based on current data: the average analyst price target is $111.31 (+43.2%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on 8/10/2026, which can move the price. Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Rocket Lab USA stock rising?
Rocket Lab USA is rising right now. The technical indicators show: the price is 10.4% above the 20-day average; short interest is 8.0% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Rocket Lab USA go?
The average analyst price target for Rocket Lab USA is $111.31, which corresponds to a potential gain of 43.2% from the current price of $77.72. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Rocket Lab USA fall?
We lack enough history to give a specific floor for Rocket Lab USA. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Rocket Lab USA do?
Rocket Lab Corporation laver rumfartsløsninger og leverer opsendelsesservices globalt. De tjener penge på at designe, producere og opsende satellitter for både regeringer og kommercielle kunder. RKLB.us er især kendt for deres lille løfteraket, Electron, som bruges til at send... The company belongs to the Industri sector, more specifically the Forsvar industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Rocket Lab USA as an investment.
Did Rocket Lab USA raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Rocket Lab USA. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Rocket Lab USA making money or losing money?
No, Rocket Lab USA is currently not making money — the company is losing money with a negative profit margin of -26.9%, a substantial loss. That means the business loses money on every dollar of revenue. For growth stocks investing in expansion this is normal — but it raises the risk if the company does not reach break-even before its capital runs out.
Can Rocket Lab USA go bankrupt?
The bankruptcy risk of Rocket Lab USA is rated as low. Altman Z2 (a model for assessing financial distress) is 5.83 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 3 — which is weak. Debt relative to equity is 210% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Rocket Lab USA have a lot of debt?
Yes, Rocket Lab USA has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 210%. For the industri sector, anything above 150% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.
